Volume 3, Issue 1, Pages (January 1999)

Slides:



Advertisements
Similar presentations
BRCA1 Is Associated with a Human SWI/SNF-Related Complex
Advertisements

Volume 5, Issue 6, Pages (June 2000)
Volume 14, Issue 3, Pages (May 2004)
Volume 6, Issue 3, Pages (September 2000)
by Xingwei Sui, Sanford B. Krantz, and Zhizhuang Zhao
Volume 94, Issue 1, Pages (July 1998)
Volume 3, Issue 1, Pages (January 1999)
Volume 26, Issue 1, Pages (April 2007)
Yan Jiang, Mingyi Liu, Charlotte A. Spencer, David H. Price 
Regulation of Ceramide Biosynthesis by TOR Complex 2
Damage-Induced Ubiquitylation of Human RNA Polymerase II by the Ubiquitin Ligase Nedd4, but Not Cockayne Syndrome Proteins or BRCA1  Roy Anindya, Ozan.
Silencing in Yeast rDNA Chromatin
RSC, an Essential, Abundant Chromatin-Remodeling Complex
Volume 2, Issue 5, Pages (November 1998)
Takashi Kubota, Kohei Nishimura, Masato T. Kanemaki, Anne D. Donaldson 
DNA Degradation at Unprotected Telomeres in Yeast Is Regulated by the CDK1 (Cdc28/Clb) Cell-Cycle Kinase  Momchil D. Vodenicharov, Raymund J. Wellinger 
Volume 8, Issue 24, Pages S (December 1998)
Volume 89, Issue 3, Pages (May 1997)
The Nuclear Hat1p/Hat2p Complex
Volume 27, Issue 2, Pages (July 2007)
Volume 91, Issue 4, Pages (November 1997)
The Putative RNA Helicase Dbp4p Is Required for Release of the U14 snoRNA from Preribosomes in Saccharomyces cerevisiae  Martin Koš, David Tollervey 
Volume 123, Issue 2, Pages (October 2005)
Cdc7-Dbf4 Phosphorylates MCM Proteins via a Docking Site-Mediated Mechanism to Promote S Phase Progression  Yi-Jun Sheu, Bruce Stillman  Molecular Cell 
Volume 2, Issue 6, Pages (December 1998)
Antonin Morillon, Nickoletta Karabetsou, Anitha Nair, Jane Mellor 
DNA Topoisomerase I and PC4 Can Interact with Human TFIIIC to Promote Both Accurate Termination and Transcription Reinitiation by RNA Polymerase III 
Hyunsuk Suh, Dane Z. Hazelbaker, Luis M. Soares, Stephen Buratowski 
Mediator–Nucleosome Interaction
Volume 125, Issue 2, Pages (April 2006)
Volume 9, Issue 6, Pages (June 2002)
Michael Kruppa, Robyn D Moir, David Kolodrubetz, Ian M Willis 
Volume 12, Issue 5, Pages (May 2007)
Volume 23, Issue 2, Pages (July 2006)
Volume 12, Issue 5, Pages (August 2015)
Volume 7, Issue 4, Pages (April 2001)
Andrei Kuzmichev, Thomas Jenuwein, Paul Tempst, Danny Reinberg 
Andrew Emili, David M Schieltz, John R Yates, Leland H Hartwell 
Volume 26, Issue 1, Pages (April 2007)
Gaku Mizuguchi, Toshio Tsukiyama, Jan Wisniewski, Carl Wu 
Volume 12, Issue 2, Pages (August 2003)
A Biochemical Function for the Sm Complex
Volume 95, Issue 2, Pages (October 1998)
Two Functional Modes of a Nuclear Receptor-Recruited Arginine Methyltransferase in Transcriptional Activation  María J. Barrero, Sohail Malik  Molecular.
A Suppressor of Two Essential Checkpoint Genes Identifies a Novel Protein that Negatively Affects dNTP Pools  Xiaolan Zhao, Eric G.D Muller, Rodney Rothstein 
Cdc18 Enforces Long-Term Maintenance of the S Phase Checkpoint by Anchoring the Rad3-Rad26 Complex to Chromatin  Damien Hermand, Paul Nurse  Molecular.
Volume 30, Issue 4, Pages (May 2008)
Volume 45, Issue 3, Pages (February 2012)
Volume 61, Issue 2, Pages (January 2016)
Volume 15, Issue 1, Pages (July 2004)
Paul B. Mason, Kevin Struhl  Molecular Cell 
Human Pre-mRNA Cleavage Factor Im Is Related to Spliceosomal SR Proteins and Can Be Reconstituted In Vitro from Recombinant Subunits  Ursula Rüegsegger,
Volume 4, Issue 5, Pages (November 1999)
Yan Jiang, Mingyi Liu, Charlotte A. Spencer, David H. Price 
Volume 14, Issue 4, Pages (May 2004)
Pantelis Hatzis, Iannis Talianidis  Molecular Cell 
Transcriptional Regulation by p53 through Intrinsic DNA/Chromatin Binding and Site- Directed Cofactor Recruitment  Joaquin M Espinosa, Beverly M Emerson 
Reconstitution of the Transcription Factor TFIIH
Volume 119, Issue 2, Pages (October 2004)
Volume 31, Issue 1, Pages (July 2008)
A Minimal RNA Polymerase III Transcription System from Human Cells Reveals Positive and Negative Regulatory Roles for CK2  Ping Hu, Si Wu, Nouria Hernandez 
Functional Coupling of Capping and Transcription of mRNA
The Yeast Capping Enzyme Represses RNA Polymerase II Transcription
Transcriptional Termination Factors for RNA Polymerase II in Yeast
Minoru Funakoshi, Robert J. Tomko, Hideki Kobayashi, Mark Hochstrasser 
Volume 41, Issue 4, Pages (February 2011)
Volume 3, Issue 1, Pages (January 1999)
Volume 123, Issue 2, Pages (October 2005)
The Engagement of Sec61p in the ER Dislocation Process
Volume 84, Issue 2, Pages (January 1996)
Presentation transcript:

Volume 3, Issue 1, Pages 109-118 (January 1999) Elongator, a Multisubunit Component of a Novel RNA Polymerase II Holoenzyme for Transcriptional Elongation  Gabriel Otero, Jane Fellows, Yang Li, Therese de Bizemont, Annette M.G Dirac, Claes M Gustafsson, Hediye Erdjument-Bromage, Paul Tempst, Jesper Q Svejstrup  Molecular Cell  Volume 3, Issue 1, Pages 109-118 (January 1999) DOI: 10.1016/S1097-2765(00)80179-3

Figure 1 Separation of Initiating and Elongating Forms of RNAPII (A) Strategy for separating the different forms of RNAPII. Only RNAPII and the GTFs of a yeast whole-cell extract are depicted. (B) Western blots of fractionated whole-cell extract proteins. Soluble (sol.) and chromatin (chrom.) fractions from a strain expressing a HA-tagged version of Rpb1 (YLC2exa) were blotted and probed with antibodies. The factor probed for is indicated on the right and the antibody used on the left. Up to 70% of RNAPII in a yeast cell is typically found in ternary complexes (Svejstrup et al. 1997). (C) Hyperphosphorylated RNAPII from the chromatin fraction is engaged in elongation. Crude chromatin was digested with DNAse and RNAse, and subjected to gel filtration through TSK G4000SW. Fractions were assayed for nucleic acid content (DNA/RNA), blotted and probed for the presence of hyperphosphorylated RNAPII (Pol II0), and tested in nonspecific transcription assays (bottom panel). The reason for the low transcription activity of fraction 32 is unknown but could be due to an inhibitory factor coeluting in this fraction. Molecular Cell 1999 3, 109-118DOI: (10.1016/S1097-2765(00)80179-3)

Figure 2 Purification of the Elongating Form of RNAPII (A) Purification protocol. (B) Purified RNA polymerase II holoenzyme. Aliquots (200 μl) from Biosil SEC400 were TCA precipitated, fractionated by SDS-PAGE through a 10% gel, and stained with silver. The migration of size markers is indicated on the left. Peak fraction 16 is shown separately on the right, with the subunits of RNAPII as well as coeluting proteins (p150, p90, and p60) indicated. Proteins labeled with asterisks also coeluted with RNAPII, but either appeared to be substoichiometric, or did not consistently copurify. (C) Western blot of the fractions in (B), probed with anti-Elp1 antibodies and antibodies specific for phosphorylated CTD. Molecular Cell 1999 3, 109-118DOI: (10.1016/S1097-2765(00)80179-3)

Figure 3 Purification of Free Elongator and Reconstitution of the RNAPII–Elongator Complex (A) Purified, free elongator. Mono Q fractions (2 μl) were fractionated by SDS-PAGE through an 8% gel and stained with silver. Size marker migration is indicated on the right. Lane 3 (fraction 25) shows virtually homogenous elongator, consisting of Elp1 (p150), p90, and p60 (indicated on left and denoted by asterisks). The weaker showing of the p90 and p60 bands compared to Elp1 is typical when small amounts of elongator are silver stained. The lower panel shows the Mono Q fractions blotted and probed with anti-Elp1 antibodies. (B) Elongator and RNAPII can associate in vitro. Elongator (100 ng Mono Q fraction 25) and RNAPII (2–300 ng) were filtrated through Superose 6, either as individual factors (upper and lower panel, respectively), or after their mixing (middle panels). The indicated fractions were blotted and probed with anti-Elp1 or anti-Rpb3 antibodies as indicated. Elution of size markers are indicated at the bottom. (C) Superose 6 elution profile of native elongating RNAPII holoenzyme. RNAPII holoenzyme purified from chromatin (hydroxylapatite fraction 20 (see Figure 4B)) was filtrated through Superose 6 as described above. Fractions were blotted and probed with anti-Elp1 antibodies. Anti-II0 antibodies showed cross-reactivity to the same fractions (data not shown). Molecular Cell 1999 3, 109-118DOI: (10.1016/S1097-2765(00)80179-3)

Figure 4 CTD Hyperphosphorylation Is Required to Maintain the Integrity of Complexes Derived from Stoichiometric Amounts of Elongator and RNAPII in Chromatin (A) Stoichiometric amounts of elongator and RNAPII in chromatin. Four and one microliters of highly purified, stoichiometric elongator–RNAPII complex (Holo-Pol II), and 0.2, 0.5, and 2 μl of crude chromatin (Chromatin) were blotted and probed with antibodies as indicated. (B) Stable elongator–RNAPII association requires CTD phosphorylation. Hydroxylapatite fractions were blotted and probed with antibodies for the factors shown on the left. Molecular Cell 1999 3, 109-118DOI: (10.1016/S1097-2765(00)80179-3)

Figure 5 Growth Phenotypes of elp1Δ Yeast Cells (A) elp1Δ cells have a “slow-start” phenotype. Tetrad dissections of elp1Δ/ELP1 diploids are shown after 32 hr and 3 days of incubation, respectively. (B) Slow adaptation phenotype of elp1Δ cells. Wild-type and elp1Δ cells were grown in YPD and transferred to either YPD (glu→glu), or YPG (glu→gal) at time 0. Cell numbers plotted versus time are shown. (C) siiΔ/elp1Δ cells are hypersensitive to the drug 6-azauracil (6-AU). Cells of the indicated phenotype were grown in SD (−ura) and plated on either SD (−ura) plates (−6AU), or on SD (−ura) plates containing 50 μg/ml 6-AU (+6AU). Molecular Cell 1999 3, 109-118DOI: (10.1016/S1097-2765(00)80179-3)

Figure 6 RNAPII Transcription in elp1Δ Mutants (A) Delayed Gal1-10 activation in elp1Δ cells. Total RNA was extracted at the times indicated after galactose addition to cells grown in raffinose, and blotted and hybridized with the indicated probes. Autoradiographs are shown. (B) Delayed Pho5 activation in elp1Δ cells. Cells were grown in YPD before transfer to low-phosphate medium (Han et al. 1988). Total RNA was extracted at the times indicated, blotted, and hybridized with the indicated probes. Autoradiographs are shown. (C) Normal levels of expression of TUB1, ACT1, and RPB2 in elp1Δ cells. Cells were grown to midlogarithmic growth phase in YPD. Total RNA was extracted, blotted, and hybridized with the indicated probes. Autoradiographs and the 28S region of ethidium bromide stained RNA gels (load control) are shown. (D) NaCl-sensitive phenotype of elp1Δ cells. Cells were plated in a dilution series (cell number shown on the left) onto YPD plates containing the salt concentration indicated. (E), Delayed ENA1 activation in elp1Δ cells. Cells were grown in YPD before adding NaCl to 1 M final concentration. Total RNA was extracted at the times indicated, blotted, and hybridized with the indicated probes. Autoradiographs are shown. A cycling pattern of transcription is typical for the expression of several stress-inducible genes in yeast. Molecular Cell 1999 3, 109-118DOI: (10.1016/S1097-2765(00)80179-3)

Figure 7 A Model for the Coupling of CTD Hyperphosphorylation/Dephosphorylation to the Formation of Distinct RNAPII Complexes during the Transcription Cycle For simplicity, other factors involved in initiation, transcript elongation, and termination have been omitted. See text for details. Molecular Cell 1999 3, 109-118DOI: (10.1016/S1097-2765(00)80179-3)